Pluri regains Nasdaq compliance after appointing audit committee chair Sep 12, 2025 08:03AM
Brainstorm Cell Therapeutics (BCLI) Secures Manufacturing Partnership with Minaris May 27, 2025 07:04AM
Pluri (PLUR) Announces Two New Patents for 3D Expansion of Immune Cells in the United States and Israel Apr 10, 2025 08:33AM
Pluri (PLUR) Announces Exclusive Collaboration Agreement with Hemafund Mar 5, 2025 07:02AM
Pluri (PLUR) Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness Mar 5, 2025 07:01AM


Feb 4, 2025 07:04AM Pluri (PLUR) Secures Additional $3.5M Investment from Major Shareholder
Jan 23, 2025 07:15AM Pluri (PLUR) Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition
Nov 12, 2024 01:00PM Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event
Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
Jul 18, 2024 08:46AM Pluri's (PLUR) CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates
Jul 8, 2024 07:01AM Pluri (PLUR) Announces EUR 1M Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply
Jul 2, 2024 06:44AM Pluri (PLUR) Announces CFO Resignation
Jun 18, 2024 06:31AM Pluri's (PLUR) Ever After Foods Secured $10M Strategic Investment